Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Stopped early · Phase 2

Conditions studied: Leukemia, Lymphoma, Low-Grade, Lymphoma, Non-Hodgkin's, Multiple Myeloma, Myelodysplastic Syndromes

In brief

This research project will focus on whether it is safe and effective to rely on donor cells to prevent relapse of leukemia, lymphoma, or other blood cancer after bone marrow stem cell transplant.

Key facts

Study ID

NCT00143884

Run by

University of Michigan Rogel Cancer Center

People needed

30

Starts

2000-03-01

Last updated by the study team

2007-04-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• The University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.